Vancouver, BC – March 27, 2020 – Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that recent developments have suggested the potential utility of its lead drug… Read More
March 26, 2020 – Vancouver, Canada — Genome BC is today launching a rapid response funding program to invest in promising research and innovation projects with the real potential to… Read More
SAN DIEGO, March 26, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced that it… Read More
Disclaimer: This document is subject to change and does not necessarily represent official, current or finalized information. Resources for Suppliers Public Services and Procurement Canada (PSPC) Calling all suppliers –… Read More
GOVERNMENT OF CANADA PROVINCE OF BC COVID 19 INFORMATION FOR EMPLOYERS AND EMPLOYEES PROVINCE OF BRITISH COLUMBIA COVID-19 Provincial Support and Information Government of Canada If you… Read More
